Imaging Agents Market
Imaging Agents Market Analysis, By Modality (Diagnostic Radiopharmaceuticals, X-Ray, CT, MRI, Ultrasound), By Product (Iodinated, Gadolinium-based, Microbubble and Barium-based Contrast Media), By Application , By End User, & By Region - Global Market Insights 2022 to 2027
Analysis of Imaging Agents Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Imaging Agents Market Outlook (2022 to 2027)
As per a new Fact.MR analysis, expanding at a CAGR of 6%, the global imaging agents market is projected to increase from a valuation of US$ 10.2 billion in 2022 to US$ 13.6 billion by the end of 2027.
The use of radiopharmaceuticals enables the diagnosis of tumour cells within organs or throughout the body. One of the main factors driving the need for diagnostic radiopharmaceuticals is the rising prevalence of acute and chronic diseases such as cancer across the world. Global sales of diagnostic radiopharmaceuticals are predicted to rise at a CAGR of 7.5% and reach a valuation of US$ 7 billion by 2027.
To improve the visualisation of body organs during an ultrasound, MRI,X-ray, and CT scans, imaging agents are a crucial part of medical imaging. Angio-radioactive PET contrast agents and nanoscale MRI contrast agents’ development generates opportunities in the imaging agents market.
Medical imaging agents are the chemicals that essentially allow doctors to see the operation of certain inside organs, tissues, or vessels during analysis or medical treatments. Medical professionals frequently employ imaging to diagnose conditions such as osteoarthritis, bone fractures, calcification, and bone loss because it helps uncover interior hidden pictures.
The past changes in the market situation are explained in 3 phases:
- Phase I (COVID-19 Outbreak) - The COVID-19 pandemic had a negligible effect on the market for imaging agents. The market saw a minor reduction in revenue in 2020 as a result of the rising number of COVID-19 cases, travel restrictions, restricted availability of hospitals, and fewer patient appointments at imaging centres for imaging treatments.
- Phase II - However, in 2021, the governments of some nations began to lift travel bans and lockdowns. This action benefited the healthcare sector's recovery and had a beneficial effect on the imaging agentsmarket. Demand for imaging agents increased as a result of the growing adoption of imaging techniques.
- Phase III - Healthcare centersresumed offering outpatient cancer care as the incidence of COVID-19-affected patients decreased globally. This led to an increase in imaging procedures and is gradually returning the procedural volume to its pre-pandemic level.
During imaging procedures, imaging agents or contrast agents are used to visualise the function of inside organs, comprising, among other aspects, chemical processes associated with blood flow, metabolism, and oxygen supply. Additionally, these agents make the targeted tissue more visible.
The capacity of molecular imaging agents to highlight minute abnormalities and to distinguish between healthy or inflamed tissues and cancer tissue based on early molecular changes rather than obvious anatomical differences makes them superior to conventional imaging agents.
In both anatomical and molecular imaging, nanoparticles represent a new class of imaging agents. Utilizing the signal strength, stability, and biodistribution characteristics of molecular imaging agents with submicron dimensions is known as nanoparticle-based imaging.
Also, high clinical trials of imaging agents are performed to improve the quality of the imaging agents. Over the coming years, the market expansion is anticipated to be driven by rising R&D expenditures, expanding healthcare infrastructure, and the use of cutting-edge imaging contrast agents.
| Report Attributes | Details |
|---|---|
| Imaging Agents Market Size (2022E) | US$ 10.2 Billion |
| Forecasted Market Value (2027F) | US$ 13.6 Billion |
| Global Market Growth Rate (2022 to 2027) | 6% CAGR |
| China Market Growth Rate (2022 to 2027) | 10% CAGR |
| China Market Value (2022) | US$ 3 Billion |
| Key Companies Profiled | GE Healthcare; Eli Lily; Bayer Healthcare Pharmaceuticals; Alliance Medical; Bracco Diagnostics, Inc.; Aytu BioScience, Inc.; Curium; Guerbet Group; Lantheus Medical Imaging, Inc.; Trivitron Healthcare; Beijing Beilu Pharmaceutical Co Ltd. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Influencing Imaging Agents Market Sales Growth?
“Rising Cases of Cancer & CVD Fuelling Demand for Imaging Agents”
Over the forecast period, it is anticipated that the rising incidence of cancer and CVD cases will fuel market demand for imaging agents.
- For instance, the World Health Organization (2022) states that cancer is the major cause of mortality globally, and accounted for around 10 million fatalities in 2020, or almost one in every six deaths.
- Additionally, the research from the same organisation states that cardiovascular diseases (CVDs), which claim a projected 17.9 million lives annually, are the most common cause of death worldwide.
The burden of cardiovascular and cancer disorders worldwide has increased as a result of rising alcohol and cigarette use. Nearly 22% of all cancer deaths are related to tobacco consumption. As a result, these factors will increase the demand for imaging procedures and imaging agents, which will be advantageous for the overall market sales of imaging agents.
Imaging tools are used to assess cancer's stages (how far along it is), as well as whether it has spread to blood vessels or essential organs. The majority of cardiac MRI procedures also employ intravenous gadolinium-based contrast agents to make the heart muscle and blood flow more visible.
The use of gadolinium-based contrast media, microbubbles contrast media, and iodine imaging agents are also becoming more common in cancer imaging techniques for the thyroid, lungs, and breasts. As a result, during the forecast period, the use of imaging agents for the pre-diagnosis of colorectal and breast cancer would gain in popularity and boost market revenue.
“High Price of Equipment & Imaging Diagnosis May Hinder Sales of Imaging Agents”
Fees of some imaging diagnosis processes are quite high depending on the type of disease one is infected with, and it may be difficult for people with low income to spend on the entire procedure. Also, the high price of some equipment is not affordable for small clinics.
Thus, it is anticipated that the high cost of imaging processes and equipment as well as the scarcity of qualified specialists will hinder the market's expansion.
Which Region is Most Targeted by Imaging Agent Producers?
“Presence of Well-established Healthcare Infrastructure in North America Attracts Major Imaging Agent Manufacturers”
The market for imaging agents in North America is forecast to expand at a healthy CAGR from 2022 to 2027 as a result of advanced medical infrastructure and R&D expenditures in the region. With its considerable initiatives, tools, and facilities of hospitals or other centres, the regional market is geared toward funding and early detection & treatment of chronic diseases.
The existence of several market players who concentrate on creating cutting-edge imaging agents for improved patient management would be beneficial for the growth of the medical imaging agents market.
The market in the Asia Pacific is expanding as a result of the region's rapidly rising rate of stroke cases, which raises demand for imaging methods and contrast materials. Major players in the Asia Pacific region are also concentrating on the development of MRI and CT angiograms of the newest generation for precise diagnostic and therapy choices.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
What is the Outlook for the U.S. Imaging Agents Market?
“Market Driven by Rising Prevalence of Cancer & Heart Disorders in the Region”
The market in the U.S. is expected to expand steadily due to an increase in cardiovascular and cancer patients. The term "heart condition" covers a wide range of conditions that can have an impact on the heart, including blood vessel diseases and genetic anomalies.
According to the Centers for Disease Control and Prevention
- A heart attack is predicted to occur in America every forty seconds.
- About 805,000 Americans experience a heart attack annually.
As a result, the growth of the industry will be aided by the rise in cardiac problems.
Lung cancer cases have increased in the United States as a result of rising tobacco consumption and smoking rates.
- The Centers for Disease Control and Prevention (CDC) estimates that 12.5% of American adults, or 30.8 million people, smoke cigarettes.
This causes an annual rise in the incidence of cancer and other diseases.
How is Demand for Imaging Agents Expected to Shape Up in China?
“Presence of Major Imaging Agent Providers in the Country”
China’s imaging agents market is predicted to increase at an impressive CAGR of 10% from 2022 to 2027 and will reach US$ 3 billion by 2027. This can be attributed to the existence of well-known local and international manufacturers in the nation, as well as the rise in healthcare spending.
- For example, one of the major contrast media manufacturing plants of GE, (General Electric Pharmaceuticals Co., Ltd.) is based in Shanghai and is a subsidiary of GE that produces diagnostic medicines (CT/MR contrast media) in China.
It is projected that this aspect will support market expansion. Growth in the market is also driven by hospitals' increasing use of advanced diagnostic tools to identify and treat diseases as well as the country's growing hospital range.
Category-wise Analysis
What is Supporting Gadolinium-based Contrast Media Sales Growth?
“High Demand for Gadolinium-based Contrast Agents as They Help Provide High-quality Imaging Scans”
Based on product type, the market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media.
The gadolinium-based contrast media segment held a 13.8% market share in 2021, and this trend will likely continue in the coming years.
Growing use of gadolinium-based contrast agents to enhance the quality of magnetic resonance imaging (MRI) scans and to detect illnesses or other abnormalities boosts the market growth.
A majority of cardiac MRI procedures also employ intravenous gadolinium-based contrast agents (GBCAs) to make the heart muscle and blood flow more visible. Additionally, the rise in cancer imaging procedures requiring gadolinium-based imaging agents, such as those for breast, thyroid, and lung cancer, would further propel market expansion.
The success of new minimally-invasive treatments can be evaluated by the urologist using gadolinium-enhanced MRI during . Such elements will quicken both market and segment growth. Also, scientists are creating novel nanoscale MRI contrast materials made of gadolinium compounds that resonate when subjected to magnetic radiation and are encased in carbon nanotubes.
Numerous advantages that this imaging agent has over competing for products ensure both segmental as well as industry expansion.
Which Application Accounts for High Demand for Imaging Agents?
“High Demand for Imaging Agents in Diagnosis of Oncology-based Disorders”
Based on application, the market is segmented into oncology, cardiology, gastrointestinal, neurology, and others.
Due to the rising prevalence and expanding need for colorectal cancer screening along with rising levels of the geriatric population, the oncology segment is anticipated to expand at a healthy rate over the forecast period. A huge population of patients with lung cancer is caused by changing lifestyles and rising smoking rates, which boosts the market value of imaging agents.
Furthermore, in oncology, imaging techniques including CT, MRA, MRI, and PET/CT are used to identify brain cancers that have broken the blood-brain barrier. The segmental expansion will be aided by this aspect. Additionally, several market participants are concentrating on expanding their image technology businesses. This will hence increase demand for imaging agents.
- To develop next-generation therapeutic radiopharmaceutical technologies for prostate cancer, for instance, Bracco Imaging launched a new subsidiary called Blue Earth Therapeutics in March 2019. This subsidiary is working to create a pipeline of therapeutic radiopharmaceuticals that are precisely targeted to expand into new cancer disease areas. The company's imaging agent business was expanded due to this tactic.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
To raise public awareness of the presence of superior imaging agents, which should accelerate the sector's growth in the coming years, major industry participants are also putting forth promotional and marketing efforts.
To maintain market competition, key players in the imaging agents market are using a variety of growth strategies with ongoing technological advancements.
- The U.S. FDA approved Lantheus' PYLARIFY, a PSMA PET imaging agent for cancer related to the prostate, in May 2021. PYLARIFY injection aids in the visualisation of soft tissue, bone, and lymph node metastases to identify the presence of advanced or recurring prostate cancer. The company's entire product portfolio has improved due to this innovative method.
- The U.S. FDA approved TAUVID and AMYVID (Florbetapir F 18 Injection) in May 2020 for Avid Radiopharmaceuticals, Inc., a division of Eli Lilly and Company. This imaging agent for positron emission tomography (PET) gives doctors useful knowledge about Alzheimer's disease. This approval aided the business in expanding its selection of imaging agents and boosted its income generation.
Key Segments in Imaging Agents Industry Research
-
By Modality:
- Diagnostic Radiopharmaceuticals
- X-ray
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Others
-
By Product:
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- Barium-based Contrast Media
-
By Application:
- Oncology
- Cardiology
- Gastrointestinal
- Neurology
- Others
-
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic & Imaging Centers
- Others
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2027)
- 6. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2027), by Modality
- 6.1. Diagnostic Radiopharmaceuticals
- 6.2. X-ray
- 6.3. Computed Tomography (CT)
- 6.4. Magnetic Resonance Imaging (MRI)
- 6.5. Ultrasound
- 6.6. Others
- 7. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2027), by Product
- 7.1. Iodinated Contrast Media
- 7.2. Gadolinium-based Contrast Media
- 7.3. Microbubble Contrast Media
- 7.4. Barium-based Contrast Media
- 8. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2027), by Application
- 8.1. Oncology
- 8.2. Cardiology
- 8.3. Gastrointestinal
- 8.4. Neurology
- 8.5. Others
- 9. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2027), by End User
- 9.1. Hospitals
- 9.2. Ambulatory Surgical Centers
- 9.3. Diagnostic & Imaging Centers
- 9.4. Others
- 10. Global Market Analysis (2017 to 2021) and Forecast (2022 to 2027), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. GE Healthcare
- 20.2. Eli Lilly
- 20.3. Bayer Healthcare Pharmaceuticals
- 20.4. Alliance Medical
- 20.5. Bracco Diagnostics, Inc.
- 20.6. Aytu BioScience, Inc.
- 20.7. Curium
- 20.8. Guerbet Group
- 20.9. Lantheus Medical Imaging, Inc.
- 20.10. Trivitron Healthcare
- 20.11. Beijing Beilu Pharmaceutical Co Ltd.
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Modality, 2017 to 2027
Table 02: Global Market Value (US$ Mn), by Modality, 2017 to 2027
Table 03: Global Market Volume (Units), by Product, 2017 to 2027
Table 04: Global Market Value (US$ Mn), by Product, 2017 to 2027
Table 05: Global Market Volume (Units), by Application, 2017 to 2027
Table 06: Global Market Value (US$ Mn), by Application, 2017 to 2027
Table 07: Global Market Volume (Units), by End User, 2017 to 2027
Table 08: Global Market Value (US$ Mn), by End User, 2017 to 2027
Table 09: Global Market Volume (Units), by Region, 2017 to 2027
Table 10: Global Market Value (US$ Mn), by Region, 2017 to 2027
Table 11: North America Market Volume (Units), by Modality, 2017 to 2027
Table 12: North America Market Value (US$ Mn), by Modality, 2017 to 2027
Table 13: North America Market Volume (Units), by Product, 2017 to 2027
Table 14: North America Market Value (US$ Mn), by Product, 2017 to 2027
Table 15: North America Market Volume (Units), by Application, 2017 to 2027
Table 16: North America Market Value (US$ Mn), by Application, 2017 to 2027
Table 17: North America Market Volume (Units), by End User, 2017 to 2027
Table 18: North America Market Value (US$ Mn), by End User, 2017 to 2027
Table 19: North America Market Volume (Units), by Country, 2017 to 2027
Table 20: North America Market Value (US$ Mn), by Country, 2017 to 2027
Table 21: Europe Market Volume (Units), by Modality, 2017 to 2027
Table 22: Europe Market Value (US$ Mn), by Modality, 2017 to 2027
Table 23: Europe Market Volume (Units), by Product, 2017 to 2027
Table 24: Europe Market Value (US$ Mn), by Product, 2017 to 2027
Table 25: Europe Market Volume (Units), by Application, 2017 to 2027
Table 26: Europe Market Value (US$ Mn), by Application, 2017 to 2027
Table 27: Europe Market Volume (Units), by End User, 2017 to 2027
Table 28: Europe Market Value (US$ Mn), by End User, 2017 to 2027
Table 29: Europe Market Volume (Units), by Country, 2017 to 2027
Table 30: Europe Market Value (US$ Mn), by Country, 2017 to 2027
Table 31: East Asia Market Volume (Units), by Modality, 2017 to 2027
Table 32: East Asia Market Value (US$ Mn), by Modality, 2017 to 2027
Table 33: East Asia Market Volume (Units), by Product, 2017 to 2027
Table 34: East Asia Market Value (US$ Mn), by Product, 2017 to 2027
Table 35: East Asia Market Volume (Units), by Application, 2017 to 2027
Table 36: East Asia Market Value (US$ Mn), by Application, 2017 to 2027
Table 37: East Asia Market Volume (Units), by End User, 2017 to 2027
Table 38: East Asia Market Value (US$ Mn), by End User, 2017 to 2027
Table 39: East Asia Market Volume (Units), by Country, 2017 to 2027
Table 40: East Asia Market Value (US$ Mn), by Country, 2017 to 2027
Table 41: South Asia Market Volume (Units), by Modality, 2017 to 2027
Table 42: South Asia Market Value (US$ Mn), by Modality, 2017 to 2027
Table 43: South Asia Market Volume (Units), by Product, 2017 to 2027
Table 44: South Asia Market Value (US$ Mn), by Product, 2017 to 2027
Table 45: South Asia Market Volume (Units), by Application, 2017 to 2027
Table 46: South Asia Market Value (US$ Mn), by Application, 2017 to 2027
Table 47: South Asia Market Volume (Units), by End User, 2017 to 2027
Table 48: South Asia Market Value (US$ Mn), by End User, 2017 to 2027
Table 49: South Asia Market Volume (Units), by Country, 2017 to 2027
Table 50: South Asia Market Value (US$ Mn), by Country, 2017 to 2027
Table 51: Latin America Market Volume (Units), by Modality, 2017 to 2027
Table 52: Latin America Market Value (US$ Mn), by Modality, 2017 to 2027
Table 53: Latin America Market Volume (Units), by Product, 2017 to 2027
Table 54: Latin America Market Value (US$ Mn), by Product, 2017 to 2027
Table 55: Latin America Market Volume (Units), by Application, 2017 to 2027
Table 56: Latin America Market Value (US$ Mn), by Application, 2017 to 2027
Table 57: Latin America Market Volume (Units), by End User, 2017 to 2027
Table 58: Latin America Market Value (US$ Mn), by End User, 2017 to 2027
Table 59: Latin America Market Volume (Units), by Country, 2017 to 2027
Table 60: Latin America Market Value (US$ Mn), by Country, 2017 to 2027
Table 61: Middle East and Africa Market Volume (Units), by Modality, 2017 to 2027
Table 62: Middle East and Africa Market Value (US$ Mn), by Modality, 2017 to 2027
Table 63: Middle East and Africa Market Volume (Units), by Product, 2017 to 2027
Table 64: Middle East and Africa Market Value (US$ Mn), by Product, 2017 to 2027
Table 65: Middle East and Africa Market Volume (Units), by Application, 2017 to 2027
Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2017 to 2027
Table 67: Middle East and Africa Market Volume (Units), by End User, 2017 to 2027
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2017 to 2027
Table 69: Middle East and Africa Market Volume (Units), by Country, 2017 to 2027
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2017 to 2027
Table 71: Oceania Market Volume (Units), by Modality, 2017 to 2027
Table 72: Oceania Market Value (US$ Mn), by Modality, 2017 to 2027
Table 73: Oceania Market Volume (Units), by Product, 2017 to 2027
Table 74: Oceania Market Value (US$ Mn), by Product, 2017 to 2027
Table 75: Oceania Market Volume (Units), by Application, 2017 to 2027
Table 76: Oceania Market Value (US$ Mn), by Application, 2017 to 2027
Table 77: Oceania Market Volume (Units), by End User, 2017 to 2027
Table 78: Oceania Market Value (US$ Mn), by End User, 2017 to 2027
Table 79: Oceania Market Volume (Units), by Country, 2017 to 2027
Table 80: Oceania Market Value (US$ Mn), by Country, 2017 to 2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2017 to 2027
Fig 02: Global Absolute $ Historical Market (2017 to 2021) and Absolute $ Opportunity (2022 to 2027), US$ Mn
Fig 03: Global Absolute Historical Volume Market (2017 to 2021) and Absolute Volume Opportunity (2022 to 2027), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2022 to 2027
Fig 06: Global Market Share, By Modality to 2022 to 2027
Fig 07: Global Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 08: Global Market Attractiveness Index, By Modality to 2022 to 2027
Fig 09: Global Market Share, By Product to 2022 to 2027
Fig 10: Global Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 11: Global Market Attractiveness Index, By Product to 2022 to 2027
Fig 12: Global Market Share, By Application to 2022 to 2027
Fig 13: Global Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 14: Global Market Attractiveness Index, By Application to 2022 to 2027
Fig 15: Global Market Share, By End User to 2022 to 2027
Fig 16: Global Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 17: Global Market Attractiveness Index, By End User to 2022 to 2027
Fig 18: Global Market Share, by Region to 2022 to 2027
Fig 19: Global Market Y-o-Y Growth Projections, by Region to 2022 to 2027
Fig 20: Global Market Attractiveness Index, by Region to 2022 to 2027
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Modality to 2022 to 2027
Fig 24: North America Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 25: North America Market Attractiveness Index, By Modality to 2022 to 2027
Fig 26: North America Market Share, By Product to 2022 to 2027
Fig 27: North America Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 28: North America Market Attractiveness Index, By Product to 2022 to 2027
Fig 29: North America Market Share, By Application to 2022 to 2027
Fig 30: North America Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 31: North America Market Attractiveness Index, By Application to 2022 to 2027
Fig 32: North America Market Share, By End User to 2022 to 2027
Fig 33: North America Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 34: North America Market Attractiveness Index, By End User to 2022 to 2027
Fig 35: North America Market Share, By Country to 2022 to 2027
Fig 36: North America Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 37: North America Market Attractiveness Index, By Country to 2022 to 2027
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Modality to 2022 to 2027
Fig 41: Europe Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 42: Europe Market Attractiveness Index, By Modality to 2022 to 2027
Fig 43: Europe Market Share, By Product to 2022 to 2027
Fig 44: Europe Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 45: Europe Market Attractiveness Index, By Product to 2022 to 2027
Fig 46: Europe Market Share, By Application to 2022 to 2027
Fig 47: Europe Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 48: Europe Market Attractiveness Index, By Application to 2022 to 2027
Fig 49: Europe Market Share, By End User to 2022 to 2027
Fig 50: Europe Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 51: Europe Market Attractiveness Index, By End User to 2022 to 2027
Fig 52: Europe Market Share, By Country to 2022 to 2027
Fig 53: Europe Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 54: Europe Market Attractiveness Index, By Country to 2022 to 2027
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Modality to 2022 to 2027
Fig 58: East Asia Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 59: East Asia Market Attractiveness Index, By Modality to 2022 to 2027
Fig 60: East Asia Market Share, By Product to 2022 to 2027
Fig 61: East Asia Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 62: East Asia Market Attractiveness Index, By Product to 2022 to 2027
Fig 63: East Asia Market Share, By Application to 2022 to 2027
Fig 64: East Asia Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 65: East Asia Market Attractiveness Index, By Application to 2022 to 2027
Fig 66: East Asia Market Share, By End User to 2022 to 2027
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 68: East Asia Market Attractiveness Index, By End User to 2022 to 2027
Fig 69: East Asia Market Share, By Country to 2022 to 2027
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 71: East Asia Market Attractiveness Index, By Country to 2022 to 2027
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Modality to 2022 to 2027
Fig 75: South Asia Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 76: South Asia Market Attractiveness Index, By Modality to 2022 to 2027
Fig 77: South Asia Market Share, By Product to 2022 to 2027
Fig 78: South Asia Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 79: South Asia Market Attractiveness Index, By Product to 2022 to 2027
Fig 80: South Asia Market Share, By Application to 2022 to 2027
Fig 81: South Asia Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 82: South Asia Market Attractiveness Index, By Application to 2022 to 2027
Fig 83: South Asia Market Share, By End User to 2022 to 2027
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 85: South Asia Market Attractiveness Index, By End User to 2022 to 2027
Fig 86: South Asia Market Share, By Country to 2022 to 2027
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 88: South Asia Market Attractiveness Index, By Country to 2022 to 2027
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Modality to 2022 to 2027
Fig 92: Latin America Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 93: Latin America Market Attractiveness Index, By Modality to 2022 to 2027
Fig 94: Latin America Market Share, By Product to 2022 to 2027
Fig 95: Latin America Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 96: Latin America Market Attractiveness Index, By Product to 2022 to 2027
Fig 97: Latin America Market Share, By Application to 2022 to 2027
Fig 98: Latin America Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 99: Latin America Market Attractiveness Index, By Application to 2022 to 2027
Fig 100: Latin America Market Share, By End User to 2022 to 2027
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 102: Latin America Market Attractiveness Index, By End User to 2022 to 2027
Fig 103: Latin America Market Share, By Country to 2022 to 2027
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 105: Latin America Market Attractiveness Index, By Country to 2022 to 2027
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Modality to 2022 to 2027
Fig 109: MEA Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 110: MEA Market Attractiveness Index, By Modality to 2022 to 2027
Fig 111: MEA Market Share, By Product to 2022 to 2027
Fig 112: MEA Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 113: MEA Market Attractiveness Index, By Product to 2022 to 2027
Fig 114: MEA Market Share, By Application to 2022 to 2027
Fig 115: MEA Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 116: MEA Market Attractiveness Index, By Application to 2022 to 2027
Fig 117: MEA Market Share, By End User to 2022 to 2027
Fig 118: MEA Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 119: MEA Market Attractiveness Index, By End User to 2022 to 2027
Fig 120: MEA Market Share, By Country to 2022 to 2027
Fig 121: MEA Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 122: MEA Market Attractiveness Index, By Country to 2022 to 2027
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2017 to 2027
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Modality to 2022 to 2027
Fig 126: Oceania Market Y-o-Y Growth Projections, By Modality to 2022 to 2027
Fig 127: Oceania Market Attractiveness Index, By Modality to 2022 to 2027
Fig 128: Oceania Market Share, By Product to 2022 to 2027
Fig 129: Oceania Market Y-o-Y Growth Projections, By Product to 2022 to 2027
Fig 130: Oceania Market Attractiveness Index, By Product to 2022 to 2027
Fig 131: Oceania Market Share, By Application to 2022 to 2027
Fig 132: Oceania Market Y-o-Y Growth Projections, By Application to 2022 to 2027
Fig 133: Oceania Market Attractiveness Index, By Application to 2022 to 2027
Fig 134: Oceania Market Share, By End User to 2022 to 2027
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User to 2022 to 2027
Fig 136: Oceania Market Attractiveness Index, By End User to 2022 to 2027
Fig 137: Oceania Market Share, By Country to 2022 to 2027
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country to 2022 to 2027
Fig 139: Oceania Market Attractiveness Index, By Country to 2022 to 2027
Fig 140: United States Market share by Modality, 2022
Fig 141: United States Market share by Product, 2022
Fig 142: United States Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 143: United States Market Share by End User, 2022
Fig 144: Canada Market share by Modality, 2022
Fig 145: Canada Market share by Product, 2022
Fig 146: Canada Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 147: Canada Market Share by End User, 2022
Fig 148: Germany Market share by Modality, 2022
Fig 149: Germany Market share by Product, 2022
Fig 150: Germany Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 151: Germany Market Share by End User, 2022
Fig 152: United Kingdom Market share by Modality, 2022
Fig 153: United Kingdom Market share by Product, 2022
Fig 154: United Kingdom Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 155: United Kingdom Market Share by End User, 2022
Fig 156: France Market share by Modality, 2022
Fig 157: France Market share by Product, 2022
Fig 158: France Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 159: France Market Share by End User, 2022
Fig 160: Russia Market share by Modality, 2022
Fig 161: Russia Market share by Product, 2022
Fig 162: Russia Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 163: Russia Market Share by End User, 2022
Fig 164: Spain Market share by Modality, 2022
Fig 165: Spain Market share by Product, 2022
Fig 166: Spain Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 167: Spain Market Share by End User, 2022
Fig 168: Italy Market share by Modality, 2022
Fig 169: Italy Market share by Product, 2022
Fig 170: Italy Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 171: Italy Market Share by End User, 2022
Fig 172: China Market share by Modality, 2022
Fig 173: China Market share by Product, 2022
Fig 174: China Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 175: China Market Share by End User, 2022
Fig 176: Japan Market share by Modality, 2022
Fig 177: Japan Market share by Product, 2022
Fig 178: Japan Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 179: Japan Market Share by End User, 2022
Fig 180: South Korea Market share by Modality, 2022
Fig 181: South Korea Market share by Product, 2022
Fig 182: South Korea Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 183: South Korea Market Share by End User, 2022
Fig 184: India Market share by Modality, 2022
Fig 185: India Market share by Product, 2022
Fig 186: India Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 187: India Market Share by End User, 2022
Fig 188: Singapore Market share by Modality, 2022
Fig 189: Singapore Market share by Product, 2022
Fig 190: Singapore Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 191: Singapore Market Share by End User, 2022
Fig 192: Indonesia Market share by Modality, 2022
Fig 193: Indonesia Market share by Product, 2022
Fig 194: Indonesia Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 195: Indonesia Market Share by End User, 2022
Fig 196: Thailand Market share by Modality, 2022
Fig 197: Thailand Market share by Product, 2022
Fig 198: Thailand Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 199: Thailand Market Share by End User, 2022
Fig 200: Brazil Market share by Modality, 2022
Fig 201: Brazil Market share by Product, 2022
Fig 202: Brazil Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 203: Brazil Market Share by End User, 2022
Fig 204: Mexico Market share by Modality, 2022
Fig 205: Mexico Market share by Product, 2022
Fig 206: Mexico Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 207: Mexico Market Share by End User, 2022
Fig 208: Turkey Market share by Modality, 2022
Fig 209: Turkey Market share by Product, 2022
Fig 210: Turkey Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 211: Turkey Market Share by End User, 2022
Fig 212: GCC Countries Market share by Modality, 2022
Fig 213: GCC Countries Market share by Product, 2022
Fig 214: GCC Countries Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 215: GCC Countries Market Share by End User, 2022
Fig 216: South Africa Market share by Modality, 2022
Fig 217: South Africa Market share by Product, 2022
Fig 218: South Africa Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 219: South Africa Market Share by End User, 2022
Fig 220: Australia Market share by Modality, 2022
Fig 221: Australia Market share by Product, 2022
Fig 222: Australia Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 223: Australia Market Share by End User, 2022
Fig 224: New Zealand Market share by Modality, 2022
Fig 225: New Zealand Market share by Product, 2022
Fig 226: New Zealand Market Value (US$ Mn) and Forecast 2022 to 2027
Fig 227: New Zealand Market Share by End User, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the estimated value of the global market for imaging agents?
The global imaging agents market is currently valued at US$ 10.2 billion.
What is the predicted growth rate for the global market for imaging agents?
Global sales of imaging agents are predicted to increase at a CAGR of 6% from 2022 to 2027.
What is the projected market value of imaging agents?
The global imaging agents market is projected to reach US$ 13.6 billion by 2027.
What is a diagnostic imaging agent?
A diagnostic imaging agent is a material used to improve contrast in images of the internal structure of the body taken using radioactive particles, sound waves, X-rays, or MRIs to identify disease.
Who are the top manufacturers of imaging agents?
Lantheus Medical Imaging, Inc., GE Healthcare, Eli Lily, Alliance Medical, Bracco Diagnostics, Inc., Bayer Healthcare Pharmaceuticals, Aytu BioScience, Inc., Curium, and Guerbet Group are some of the major companies in the imaging agents market.
Imaging Agents Market